Syncom Formulations Files SEBI Compliance Certificate for Q1 FY27
Syncom Formulations (India) Limited submitted a compliance certificate for Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate covers the quarter ended June 30, 2026, and was provided by the Registrar and Share Transfer Agent, Ankit Consultancy Pvt. Ltd.
This is a standard regulatory filing that is required periodically and does not involve any new business developments, financial results, or strategic changes that would significantly impact the company.
The announcement is a routine compliance filing and does not contain any information that positively or negatively impacts the company's operations or financial standing.
Syncom Formulations (India) Limited has submitted a certificate confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate, received from their Registrar and Share Transfer Agent, M/s Ankit Consultancy Pvt. Ltd., pertains to the quarter ended 30th June, 2026.
The certificate confirms that securities received from depository participants for dematerialization during the specified quarter were processed and confirmed to the depositories. It also states that the cancelled security certificates have had the depositories substituted as the registered owner in the register of members within the stipulated 15-day period.
The company has filed this online with BSE Limited and the National Stock Exchange of India Limited for their records.
What to do with a filing like this
Syncom Formulations (India) Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Syncom Formulations (India) Limited. Read the original for the full detail.